If you have extra medication nearing expiration, contact PlexusDx support to discuss proper disposal or next-dose timing
How Mochi Health Compares to the Standard of Care The American Association of Clinical Endocrinology (AACE) 2023 obesity management algorithm recommends that patients with BMI 30 (or BMI 27 with at least one obesity-related comorbidity) be offered pharmacotherapy alongside lifestyle intervention, with prescriber follow-up at 4, 8, and 12 weeks after initiation, then every 3 months [13]
10.1530/JOE-23-0342 J Endocrinol
It is a prescription medicine with a defined role in diabetes and obesity care, it can help with glycaemic control and weight reduction, but it can also cause nausea, vomiting, constipation and other gastrointestinal side effects
First, a couple things to be aware of: Everyone is different so results can vary